The recent reports by Bose and colleagues [1] and by Yanai [2] in this journal review the contemporary data on the management of patients infected with the severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019 (COVID-19), and provide a meta-analysis of the prevalence of diabetes and hypertension among COVID-19 patients with severe vs. non-severe disease, respectively. Both studies provide timely contributions on key clinical and epidemiological issues crucial to clinicians and scientists in the face of the evolving COVID-19 pandemic, as clinicians have been accustomed to instantly accessible high-quality information to support evidence-based decisions.
展开▼